Latest Data Demonstrate Potential of the Swoop® Portable MR
New study utilizes Hyperfine, Inc. portable MRI system in monitoring brain injury and evaluating physiological impacts...
Stay updated with breaking news from Stroke Conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New study utilizes Hyperfine, Inc. portable MRI system in monitoring brain injury and evaluating physiological impacts...
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients DUBLIN and DALLAS, Feb. 8, 2023 /CNW/ -- Medtronic today... | February 8, 2023
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announce
The ENCHANTED2/MT trial, which was investigating intensive lowering of blood pressure in acute ischemic stroke patients after mechanical thrombectomy, has been stopped early due to safety concerns.
Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.